The New Cannabis ETF Is Already Making Additions

The AdvisorShares Pure Cannabis ETF YOLO debuted last week as just the second U.S. ETF dedicated to marijuana.

What Happened

Although Tuesday was just YOLO's third day on the market, the fund's portfolio manager Dan Ahrens already made some additions to YOLO's roster.

Greenlane Holdings Inc. GNLN, the Florida-based maker of cannabis vape hardware and related accessories, commenced an initial public offering on April 17, the day before YOLO debuted. That stock is now part of YOLO's lineup at a weight of almost 3 percent.

“We kept eyeballs on that [the Greenlane IPO], did not want to buy it as part of the IPO,” Ahrens said in a video posted on Twitter. “Yesterday [April 22], the stock dipped... We bought shares of Greelane Holdings."

Why It's Important

YOLO also added shares of Israeli biotechnology firm Intec Pharma Ltd. NTEC. With a market value of just over $207 million, NTEC now commands a weight of almost 2 percent in YOLO.

Arena Pharmaceuticals, Inc. ARNA, a California-based biotechnology company working on a cannabinoid receptor to treat abdominal pain and irritable bowl syndrome (IBS), was also added to YOLO's roster. Shares of Arena are YOLO's smallest holding at a weight of 1.92 percent.

In the Twitter video, Ahrens noted the Arena and Intec positions are small, but highlighted the fund being actively managed, meaning the managers can add, drop or adjust holdings as they see fit. YOLO's primary rival among the U.S.-listed cannabis ETFs, the ETFMG Alternative Harvest ETF MJ, is a passively managed index-based ETF.

What's Next

On Tuesday, Canada-based Aleafia Health Inc. ALEAF, which calls itself “a vertically integrated cannabis health and wellness company,” said it was added to YOLO, too.

Aleafia has a 2.66-percent weight in the new marijuana ETF.

Related Links

A Cheap EM ETF

A Unique Bond ETF

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisSector ETFsNew ETFsTop StoriesMarketsETFsAdvisorSharesDan Ahrens
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.